Outcome of patients with relapsed or refractory acute myeloid leukemia treated with Mito-FLAG salvage chemotherapy

被引:0
|
作者
Regina Mühleck
Sebastian Scholl
Inken Hilgendorf
Karin Schrenk
Jakob Hammersen
Jochen J. Frietsch
Maximilian Fleischmann
Herbert G. Sayer
Anita Glaser
Andreas Hochhaus
Ulf Schnetzke
机构
[1] Universitätsklinikum Jena,Klinik für Innere Medizin II, Abteilung für Hämatologie und Internistische Onkologie
[2] HELIOS Klinikum Erfurt,4. Medizinische Klinik
[3] Universitätsklinikum Jena,Institut für Humangenetik
关键词
AML; Refractory; Relapse; Salvage therapy; Mito-FLAG;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2539 / 2548
页数:9
相关论文
共 50 条
  • [31] Differential Outcomes of Salvage with FLAG-IDA and Venetoclax-Based Regimens in Relapsed and Refractory Acute Myeloid Leukemia
    Bouligny, Ian M.
    Maher, Keri R.
    BLOOD, 2021, 138
  • [32] FLAG with Oral Fludarabine for Primary Refractory or Relapsed Acute Lymphoid or Myeloid Leukemia
    Demichelis, Roberta
    Crespo, Erick
    Perez, Fernando
    Valencia, Ubaldo
    Guzman, Patricia
    BLOOD, 2014, 124 (21)
  • [33] Impact of pretreatment characteristics and salvage strategy on outcome in patients with relapsed acute myeloid leukemia
    R F Schlenk
    P Frech
    D Weber
    P Brossart
    H-A Horst
    D Kraemer
    G Held
    M Ringhoffer
    A Burchardt
    G Kobbe
    K Götze
    D Nachbaur
    T Fischer
    M Lübbert
    H R Salih
    H Salwender
    G Wulf
    E Koller
    M Wattad
    W Fiedler
    S Kremers
    H Kirchen
    B Hertenstein
    P Paschka
    V I Gaidzik
    V Teleanu
    M Heuser
    F Thol
    K Döhner
    J Krauter
    A Ganser
    H Döhner
    Leukemia, 2017, 31 : 1217 - 1220
  • [34] Venetoclax Combined With FLAG-IDA in Refractory or Relapsed Acute Myeloid Leukemia
    Wille, Kai
    Dumke, Marvin
    Wilsdorf, Nadine
    Sadjadian, Parvis
    Schneider, Artur
    Jender-Bartling, Stephanie
    Kolatzki, Vera
    Horstmann, Anette
    Meixner, Raphael
    Jimenez-Munoz, Marina
    Fuchs, Christiane
    Tischler, Hans-Joachim
    Griesshammer, Martin
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2025, 114 (01) : 17 - 25
  • [35] Impact of pretreatment characteristics and salvage strategy on outcome in patients with relapsed acute myeloid leukemia
    Schlenk, R. F.
    Frech, P.
    Weber, D.
    Brossart, P.
    Horst, H-A
    Kraemer, D.
    Held, G.
    Ringhoffer, M.
    Burchardt, A.
    Kobbe, G.
    Goetze, K.
    Nachbaur, D.
    Fischer, T.
    Luebbert, M.
    Salih, H. R.
    Salwender, H.
    Wulf, G.
    Koller, E.
    Wattad, M.
    Fiedler, W.
    Kremers, S.
    Kirchen, H.
    Hertenstein, B.
    Paschka, P.
    Gaidzik, V. I.
    Teleanu, V.
    Heuser, M.
    Thol, F.
    Doehner, K.
    Krauter, J.
    Ganser, A.
    Doehner, H.
    LEUKEMIA, 2017, 31 (05) : 1217 - 1220
  • [36] A Prognostic Index for Patients with Refractory or in First Relapsed Acute Myeloid Leukemia Treated with FLAG-Ida or Flago-Ida
    Miguel Bergua, Juan
    Montesinos, Pau
    Martinez-Cuadron, David
    Fernandez-Abellan, Pascual
    Serrano, Josefina
    Jose Sayas, Maria
    Prieto-Fernandez, Julio
    Garcia, Raimundo
    Julia Garcia-Huerta, Ana
    Barrios, Manuel
    Perez-Lopez, Cristina
    Perez-Encinas, Manuel
    Siemele, Adriana
    Rodriguez-Macias, Gabriela
    Herrera-Puente, Pilar
    Rodriguez-Veiga, Rebeca
    Pilar Martinez-Sanchez, Maria
    Lourdes Amador-Barciela, Maria
    Sanz, Miguel A.
    BLOOD, 2014, 124 (21)
  • [37] FLAG-Ida Regimen as Bridge Therapy to Allotransplantation in Refractory/Relapsed Acute Myeloid Leukemia Patients
    Delia, Mario
    Pastore, Domenico
    Cariuccio, Paola
    Paseiolla, Crescenza
    Ricco, Alessandra
    Rossi, Antonella Russo
    Casieri, Paola
    Mestice, Anna
    Albano, Francesco
    Specchia, Giorgina
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (11): : 767 - 773
  • [38] OUTCOME OF FLAG REGIMEN IN THE TREATMENT OF REFRACTORY OR RELAPSED ADULT ACUTE MYLOID LEUKEMIA
    Alwan, F.
    Matti, F.
    Naji, S.
    Almudhaffar, J.
    HAEMATOLOGICA, 2012, 97 : 507 - 507
  • [39] Successful Salvage Treatment With Clofarabine and Cytarabine In Relapsed/Refractory Acute Myeloid Leukemia
    Malato, Alessandra
    Acquaviva, Francesco
    Santoro, Alessandra
    Felice, Rosaria
    Magrin, Silvana
    Turri, Diamante
    Scime, Rosanna
    Di Bella, Raimondo
    Salemi, Domenico
    Fabbiano, Francesco
    BLOOD, 2013, 122 (21)
  • [40] FLAG-lite regimen is effective bridging salvage chemotherapy for relapsed/refractory acute myeloid Leukaemia - a single centre experience
    Mehra, V.
    Raj, K.
    Potter, V.
    Mclornan, D.
    de lavallade, H.
    Hayden, J.
    Ong, G.
    Cave, D.
    Kulasekararaj, A.
    Pagliuca, T.
    Mufti, G. J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 : 137 - 137